Addition of prokinetic therapy to a PPI in reflux diseases

Alimentary Pharmacology and Therapeutics

Volumn 33, Issue 8, 2011, Pages 983-984

  Hsu, Y C ^a   Lin, H J ^b  

^a E DA HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

MOSAPRIDE CITRATE; PLACEBO; PROTON PUMP INHIBITOR;

ADJUVANT THERAPY; DRUG EFFICACY; GASTROESOPHAGEAL REFLUX; HUMAN; LETTER; MONOTHERAPY; NON EROSIVE REFLUX DISEASE; PRIORITY JOURNAL; REFLUX ESOPHAGITIS;

BENZAMIDES; DRUG THERAPY, COMBINATION; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL AGENTS; HUMANS; MORPHOLINES; PROTON PUMP INHIBITORS;

EID: 79952791700     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2011.04595.x     Document Type: Letter

References (5)

1. Miwa H, Inoue K, Ashida K, et al. Randomised clinical trial: efficacy of the addition of a prokinetic, mosapride citrate, to omeprazole in the treatment of patients with non-erosive reflux disease-a double-blind, placebo-controlled study. Aliment Pharmacol Ther 2011; 33: 323-32.
2. Hsu YC, Yang TH, Hsu WL, et al. Mosapride as an adjunct to lansoprazole for symptom relief of reflux oesophagitis. Br J Clin Pharmacol 2010; 70: 171-9.
3. Khan M, Santana J, Donnellan C, Preston C, Moayyedi P,. Medical treatments in the short term management of reflux oesophagitis. Cochrane Database Syst Rev 2007; 2: CD003244.
4. Hershcovici T, Fass R,. Nonerosive reflux disease (NERD)-an update. J Neurogastroenterol Motil 2010; 16: 8-21.
5. Fass R, Shapiro M, Dekel R, Sewell J,. Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease-where next? Aliment Pharmacol Ther 2005; 22: 79-94. (Pubitemid 41039696)